|
PAK2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.025400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.911000E-01 |
| Normal-vs-Stage2 |
3.648600E-01 |
| Normal-vs-Stage3 |
7.359800E-02 |
| Normal-vs-Stage4 |
1.190790E-01 |
| Stage1-vs-Stage2 |
4.097600E-01 |
| Stage1-vs-Stage3 |
2.892200E-02 |
| Stage1-vs-Stage4 |
2.016600E-01 |
| Stage2-vs-Stage3 |
3.814000E-01 |
| Stage2-vs-Stage4 |
5.368000E-01 |
| Stage3-vs-Stage4 |
8.688600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.091000E-01 |
| Normal-vs-AfricanAmerican |
4.273000E-01 |
| Normal-vs-Asian |
9.878800E-01 |
| Caucasian-vs-AfricanAmerican |
8.933000E-01 |
| Caucasian-vs-Asian |
7.873200E-01 |
| AfricanAmerican-vs-Asian |
7.342000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.569000E-01 |
| Normal-vs-Female |
1.395600E-02 |
| Male-vs-Female |
1.356240E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.465200E-01 |
| Normal-vs-Extreme_Weight |
4.899600E-01 |
| Normal-vs-Obese |
1.003790E-01 |
| Normal-vs-Extreme_Obese |
9.756400E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.099600E-01 |
| Normal_Weight-vs-Obese |
1.844000E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.955800E-01 |
| Extreme_Weight-vs-Obese |
1.566390E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.997000E-01 |
| Obese-vs-Extreme_Obese |
4.336000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.475370E-01 |
| Normal-vs-Age(41-60Yrs) |
2.590200E-02 |
| Normal-vs-Age(61-80Yrs) |
6.347400E-01 |
| Normal-vs-Age(81-100Yrs) |
6.676000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.345600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.026610E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.194160E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.260620E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.504640E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.189200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.761400E-01 |
| Normal-VS-Type2 PRCC |
3.741000E-01 |
| Normal-VS-KIRP CIMP |
1.001730E-02 |
| Normal-VS-Unclassified PRCC |
1.855630E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.948600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.37810000000005E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
2.772800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.238000E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
4.487800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.113500E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.665000E-01 |
| Normal-vs-N1 |
1.067810E-02 |
| Normal-vs-N2 |
5.129200E-01 |
| N0-vs-N1 |
2.404400E-03 |
| N0-vs-N2 |
1.328220E-01 |
| N1-vs-N2 |
7.657600E-01 |
|
|
